Instrument Inactif

Autres langues ALPA HEAL

Actions

ALPA

US02073F1049

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary	20/03
Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field	18/03
Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024	26/02
Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors	16/11
ALPA HEAL : Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors - Form 8-K	16/11
Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11
Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics	06/09/23
Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
ALPA HEAL : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K	21/07/23
Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation	17/07/23
Alpha Healthcare Acquisition Corp. III(NasdaqCM:ALPA) dropped from NASDAQ Composite Index	17/07/23
Alpha Healthcare Acquisition Completes Combination With Carmell Therapeutics	14/07/23
Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation	14/07/23
Carmell Therapeutics Corporation completed the acquisition of Alpha Healthcare Acquisition Corp. III from a group of shareholders in a reverse merger transaction.	14/07/23
Alpha Healthcare Acquisition III : Material Agreement - Form 8-K	10/07/23
Carmell Therapeutics Merger With Alpha Healthcare Acquisition Corp III (Nasdaq: ALPA) July 6, 2023 - Form 8-K	06/07/23
Alpha Healthcare Acquisition Executes Non-Binding Letter of Intent to Acquire Regenerative Medicine Company	27/06/23
Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination	27/06/23
Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
ALPHA HEALTHCARE ACQUISITION CORP III : Other Events (form 8-K)	02/05/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues ALPA HEAL

Actions

ALPA

US02073F1049

Autres langues

Filtres